Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes an identifiable offering/initiative that is still smaller part of overall results, with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. Look for such an offering. Candidates: Premier Protein powders? Dymatize? International? Single-serve? GLP-1 related? Licensing? Let's scan. Darcy mentions: "Premier Protein saw great success this year in other forms, showing the power of the brand. In Q4, Premier Protein powders remain strong, growing over 50% behind new distribution and strong velocities. It reached over $50 million in net sales this year, and we expect robust growth in '24 as we invest behind marketing programs to drive awareness." That's a product line (powders) that is smaller relative to shakes. But is there indication that customer response is running ahead of what company prepared for? They say "growing over 50% behind new distribution and strong velocities." That's strong growth, but not explicitly that it exceeded preparation. Also they say "we expect robust growth in '24 as we invest behind marketing programs" - that's future investment, not necessarily current response. No mention of demand exceeding supply or capacity for powders. Another candidate: Dymatize? That's a brand, but it's a major brand, not small relative to total? Dymatize is significant. Also they talk about launching new marketing campaign in '24, but that's future. What about the GLP-1 opportunity? They mention research and testing media, but that's future, not current uptake. What about the new co-man capacity? That's supply side, not an offering. What about the relaunched flavors? They mention "relaunched shake flavors and seasonal offerings continue to drive incremental sales." But that's part of main business. What about the licensing strategy? "our licensing strategy continues to perform well. Although not a significant revenue driver, we are encouraged that the brand has seen success in other high-traffic aisles." That's small, but no mention of demand ahead of plan or company responding now. What about the international business? They say it's growing strongly but slower build, not ahead of plan. What about the single-serve? They say it's an opportunity, but not current. Look for any explicit statement of demand exceeding preparation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).